Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
Clinical trial NCT03029247 · COMPLETED
Trial details
- NCT number
- NCT03029247
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-27
- Primary completion
- 2020-07-09
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.